| Advice Pool |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Diabetes > Diabetes Cure - A Dream Or A Reality? |
|
Advice Pool - Diabetes Cure - A Dream Or A Reality?
As the number of diabetes cases steadily grows, those diagnosed and involved in the care of diabetes p According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product atients have elected to focus on three options: prevent, cure and provide better care for those afflic ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ed. Many look to prevent diabetes by organizing programs that educate and bring public awareness to t lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. e various aspects of diabetes. By reaching the masses and bringing this awareness, those who heed the here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe alue of the message can keep themselves from becoming one of the millions of sufferers. Stopping comp d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro lications of diabetes are some of the reasons why so much research is done today all over the world. E ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc en with daily insulin shots, can type 1 diabetes patients still develop complications. Sometimes with easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ood sugar control the process of deterioration continues to go on. The diabetes industry had to try fi nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ding alternative ways to curb the problem. Special groups raise millions of dollars every year to hel and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ p fund research for a diabetes cure in the hope that soon, loved ones will no longer be ravaged by its ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi complications. Advances in technology continue to help provide better care for those who suffer from t ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a e complications of diabetes and make life a happy healthy journey. Alternative Approaches to Curing D dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod abetes Also Being Pursued: •Pancreas cell transplants. Doctors are transplanting islet cells from a d cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin onor pancreas to provide a cure for some patients. •Development of artificial pancreas cells •Geneti tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen manipulation with fat and/or muscle cells that don’t normally make insulin, yet are able to do so whe t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel a human insulin gene is inserted Each of these approaches presents a unique challenge. Be it preven ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ing the rejection of the procedure by the immune system itself to finding an adequate number of insuli y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products n cells and keeping them alive, rest assured that each challenge is being met with progress and great . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de trides are consistently being made in the search for a cure to diabetes. Although much have been done elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip so far, the challenge of finding a cure for most of the diabetic patients out there is still wide open tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:I Would Like to Start a Mobile Car Wash Company Ways For Personalizing Your Cell Phone
|